Adjusting your routine will keep your body guessing and ensure you continue to see results
Retatrutides eventual licensed indications will depend on which TRIUMPH and TRANSCEND trials produce positive results and which Lilly applies for
As Healio previously reported, in the STEP 1 study, published in The New England Journal of Medicine in February, adults with obesity assigned semaglutide 2.4 mg experienced substantial weight loss compared with placebo, with more than half of participants losing 15% of their body weight
Retatrutide activates three: GLP-1, GIP, and glucagon
Retatrutide goes further still, adding glucagon receptor (GCGR) agonism to the GLP-1 and GIP receptor profile making it a triple-receptor research compound that attracts interest from researchers studying energy expenditure at the highest signalling complexity
When to Expect Appetite Changes Initial Effects (1-2 Weeks): Semaglutide GLP-1 begins to show effects relatively quickly, but most users notice significant changes in appetite within the first 1 to 2 weeks
